The Biden Administration’s pledge of medical aid for India to combat the country’s surge of COVID-19 shows an important commitment to tackling the pandemic as a shared crisis. We commend the Administration for taking this step and for its plans to share up to 60 million doses of the AstraZeneca vaccine.

IDSA and HIVMA offer to partner on controlling COVID-19 and other pressing public health issues, including the HIV, sexually transmitted infections (STIs) and viral hepatitis syndemics and antimicrobial resistance (AMR).

Our colleagues are committed to blazing trails in the field of infectious diseases. Fellowship in IDSA honors members who have worked tirelessly to achieve professional excellence through significant service to the field in clinical practice, research, administration or education.

“President Biden’s budget proposal, with a request for $670 million for expanded access to antiretroviral treatment and pre-exposure prophylaxis -- PrEP -- to prevent HIV transmissions as well as improved access to routine and critical health services

The HIV Medicine Association and the Infectious Diseases Society of America applaud the introduction of legislation on Friday by Rep. Lisa Blunt Rochester (D-AL) to address the critical shortage of clinicians and dentists caring for people with HIV

An issue brief highlighting delivery system, staffing and administrative issues for clinics and clinicians to consider in preparing for the availability of long-acting antiretroviral treatment.